TITLE:
Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

CONDITION:
HIV Infections

INTERVENTION:
capravirine

SUMMARY:

      This is a 48 week study for HIV-infected patients who have failed several regimens including
      PI's, NNRTs and NRTIs. Patients will be randomly selected to be in 1 of 4 groups. Three of
      the 4 groups will contain capravirine in different doses combined with Kaletra and
      nucleosides and one of the groups will be a combination of Kaletra and nucleosides without
      the capravirine.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  HIV-infected male or female at least 18 years of age

          -  HIV RNA level >1000 copies/mL at screening

          -  Subject has failed regimens that included at least 1 protease inhibitor but not more
             than 3 protease inhibitors, at least 1 nonnucleoside reverse transcriptase inhibitor,
             and least 2 nucleoside reverse transcriptase inhibitors

          -  Adequate renal function

          -  Adequate hematological function

          -  Adequate liver function

        Exclusion Criteria:

          -  Women who are pregnant or lactating

          -  No previous experience with Kaletra
      
